Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 1997

View Archived Issues

Sigma-Tau reports therapeutically active seco-D steroid derivatives

New dopamine receptor ligands reported by Roche

Takeda discloses lankacidin derivatives

Anticancer/antimetastatic agents from Sankyo

Japanese investigators isolate novel aminopeptidase inhibitor

Novel antioxidant disclosed by Nippon Chemiphar

Terumo prepares smooth muscle cell proliferation inhibitors

Hypoglycemic agents from Nippon Chemiphar

Therapeutically active glycomimetic saccharopeptides from Glycomed

Merck & Co. claims FPTase inhibitors for cancer

Immunotherapeutic vaccine for CML reported in patent literature

Pfizer investigates beta-adrenoceptor agonists

Pfizer reports new GH stimulants

Isis and UCSF awarded grant for combinatorial drug discovery

Company Profile: Advanced Plant Pharmaceuticals

Company Profile: Structural Bioinformatics

Company Profile: Cortex

Cortecs signs first European licensing agreement for oral calcitonin

Tularik, Merck & Co. extend R&D agreement

Antisense mechanism of Isis/Ciba compound demonstrated

SnET2 trials now span three continents

Panax acquires colon-clearing drug for colonoscopy preparation

CPMP approves unified labeling for Intron A

Gensia stockholders to vote on proposed acquisitions

Terrapin, Sanwa establish diabetes R&D collaboration

AutoImmune updates clinical program for oral RA product

AI-401 clinical trial program updated

MacroChem to begin clinical trials of SEPA-testosterone

New treatment option for HIV-infected children

AltaRex's lead product given orphan drug status

Neovastat enters clinic in the U.S.

Obstacles to tolerance induction in the treatment of autoimmune disease

Medarex forms European subsidiary and research alliance

Name change for Anika

Techniclone seeks to control Peregrine

Conclusion of Cephalon/Schering-Plough AD collaboration

New tumor immunotherapy approach described by U.S. academic researchers

Hybridon to begin French clinical trials on anti-CMV antisense compound

IDEC licenses technology to Boehringer Ingelheim

FDA approves topical acne treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...